Aflibercept/bevacizumab/triamcinoloneLack of efficacy during treatment of macular oedema secondary to central retinal vein occlusion: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1896卷 / 1期
关键词：
D O I：
10.1007/s40278-022-10817-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：26 / 26
相关论文
共 50 条
  • [31] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    K-C Cheng
    W-C Wu
    K-J Chen
    Eye, 2009, 23 : 2023 - 2033
  • [32] The use of aflibercept in the management of macular edema secondary to central retinal vein occlusion
    Kim, Daniel Dae
    Saraf, Steven
    Desai, Ankit
    Desai, Uday
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [33] Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
    Becky Pennington
    Abualbishr Alshreef
    Laura Flight
    Andrew Metry
    Edith Poku
    Philip Hykin
    Sobha Sivaprasad
    A. Toby Prevost
    Joana C. Vasconcelos
    Caroline Murphy
    Joanna Kelly
    Yit Yang
    Andrew Lotery
    Michael Williams
    John Brazier
    PharmacoEconomics, 2021, 39 : 1099 - 1099
  • [34] Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion
    Balla, Szabolcs
    Zold, Eszter
    Potor, Laszlo
    Lukucz, Balazs
    Vajas, Attila
    Ujhelyi, Bernadett
    Nagy, Valeria
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (05) : 2528 - 2534
  • [35] Aflibercept versus dexamethasone in macular edema secondary to central retinal vein occlusion
    Garreton, Rodolfo
    Gonzalez, Raul
    MEDWAVE, 2019, 19 (11):
  • [36] Effect of aflibercept on persistent macular edema secondary to central retinal vein occlusion
    Kaya, F.
    Kocak, I
    Aydin, A.
    Baybora, H.
    Koc, H.
    Karabela, Y.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (09): : 809 - 813
  • [37] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion
    Wu, W-C
    Cheng, K-C
    Wu, H-J
    EYE, 2009, 23 (12) : 2215 - 2222
  • [38] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion
    W-C Wu
    K-C Cheng
    H-J Wu
    Eye, 2009, 23 : 2215 - 2222
  • [39] Real world clinical audit of aflibercept and ranibizumab use in the management of macular oedema secondary to central retinal vein occlusion
    Elatfy, Mohammed
    Than, Jonathan
    Palexas, George
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [40] Intravitreal aflibercept for macular oedema due to branch retinal vein occlusion
    Clark, W. L.
    Brown, D.
    Stemper, B.
    ACTA OPHTHALMOLOGICA, 2014, 92
12345